| OncoboxPD: Human 51 672 molecular pathways database with tools for activity calculating and visualization MA Zolotovskaia, VS Tkachev, AA Guryanova, AM Simonov, MM Raevskiy, ... Computational and Structural Biotechnology Journal 20, 2280-2291, 2022 | 19 | 2022 |
| Machine learning applicability for classification of PAD/VCD chemotherapy response using 53 multiple myeloma RNA sequencing profiles N Borisov, A Sergeeva, M Suntsova, M Raevskiy, N Gaifullin, ... Frontiers in Oncology 11, 652063, 2021 | 17 | 2021 |
| Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma M Sorokin, M Raevskiy, A Zottel, N Šamec, M Skoblar Vidmar, A Matjašič, ... Cancers 13 (14), 3419, 2021 | 16 | 2021 |
| Reclassification of TCGA diffuse glioma profiles linked to transcriptomic, epigenetic, genomic and clinical data, according to the 2021 WHO CNS tumor classification G Zakharova, V Efimov, M Raevskiy, P Rumiantsev, A Gudkov, ... International journal of molecular sciences 24 (1), 157, 2022 | 13 | 2022 |
| Human blood serum can donor-specifically antagonize effects of EGFR-targeted drugs on squamous carcinoma cell growth D Kamashev, M Sorokin, I Kochergina, A Drobyshev, U Vladimirova, ... Heliyon - Cell Press 7 (3), 2021 | 10 | 2021 |
| Better Agreement of Human Transcriptomic and Proteomic Cancer Expression Data at the Molecular Pathway Activation Level M Raevskiy, M Sorokin, G Zakharova, V Tkachev, N Borisov, D Kuzmin, ... International Journal of Molecular Sciences 23 (5), 2611, 2022 | 6 | 2022 |
| Residual life prediction of gas-engine turbine blades based on damage surrogate-assisted modeling B Vasilyev, S Nikolaev, M Raevskiy, S Belov, I Uzhinsky Applied Sciences 10 (23), 8541, 2020 | 6 | 2020 |
| Epi-impute: single-cell rna-seq imputation via integration with single-cell atac-seq M Raevskiy, V Yanvarev, S Jung, A Del Sol, YA Medvedeva International Journal of Molecular Sciences 24 (7), 6229, 2023 | 5 | 2023 |
| Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition D Kamashev, N Shaban, M Suntsova, M Raevskiy, V Efimov, A Moisseev, ... Biomedicines 10 (8), 1914, 2022 | 5 | 2022 |
| In silico drug repurposing in multiple Sclerosis using scRNA-Seq data A Shevtsov, M Raevskiy, A Stupnikov, Y Medvedeva International Journal of Molecular Sciences 24 (2), 985, 2023 | 4 | 2023 |
| Human blood serum can diminish EGFR-targeted inhibition of squamous carcinoma cell growth through reactivation of MAPK and EGFR pathways D Kamashev, N Shaban, T Lebedev, V Prassolov, M Suntsova, ... Cells 12 (16), 2022, 2023 | 3 | 2023 |
| Transcriptomic portraits and molecular pathway activation features of adult spinal intramedullary astrocytomas N Konovalov, S Timonin, D Asyutin, M Raevskiy, M Sorokin, AA Buzdin, ... Frontiers in Oncology, 942, 2022 | 3 | 2022 |
| EGFR Pathway-Based Gene Signatures of Druggable Gene Mutations in Melanoma, Breast, Lung, and Thyroid Cancers M Raevskiy, M Sorokin, U Vladimirova, M Suntsova, V Efimov, A Garacha, ... Biochemistry (Moscow) 86, 1477-1488, 2021 | 3 | 2021 |
| Sample-Wise and Gene-Wise Comparisons Confirm a Greater Similarity of RNA and Protein Expression Data at the Level of Molecular Pathways and Suggest an Approach for the Data … M Raevskiy, M Sorokin, A Emelianova, G Zakharova, E Poddubskaya, ... Biochemistry (Moscow) 89 (4), 737-746, 2024 | | 2024 |
| Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression N Shaban, M Raevskiy, G Zakharova, V Shipunova, S Deyev, M Suntsova, ... Biochemistry (Moscow) 89 (3), 487-506, 2024 | | 2024 |
| scATAC-seq preprocessing and imputation evaluation system for visualization, clustering and digital footprinting P Akhtyamov, L Shaheen, M Raevskiy, A Stupnikov, YA Medvedeva Briefings in Bioinformatics 25 (1), bbad447, 2024 | | 2024 |
| Improving prediction of core transcription factors for cell reprogramming and transdifferentiation M Raevskiy, A Kondrashina, Y Medvedeva F1000Research 11, 38, 2022 | | 2022 |
